● Recruiting

Immunogenicity of Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Condition: Shingles · Sponsor: Loyola University

PhasePhase 2

Planned participants100

Who can joinAll sexes, N/A to no upper limit

Healthy volunteersNo

About this study

This is a phase II study that will examine the immunogenicity of the Shingrix vaccine in patients following an allogeneic stem cell transplant.

This description comes directly from the study's public registry record.

Talk to the study team

Patrick A Hagen · 708-327-3810 · patrick.hagen@lumc.edu

Mary Lee · 708-327-2241

Always discuss trial participation with your own doctor first.

Locations (1)

Loyola University Medical Center

Maywood, Illinois, United States

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05554068